Original,O
Investigation,O
|,O
Psychiatry,O
Prevalence,O
of,O
and,O
Risk,O
Fac,O
‐,O
tors,O
Associated,O
With,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
in,O
China,COUNTRY
During,O
the,O
Coronavirus,O
Disease,CAUSE_OF_DEATH
2019,DATE
Pandemic,O
Le,PERSON
Shi,PERSON
.,O
PhD,O
;,O
Zheng,PERSON
‐,PERSON
An,PERSON
Lu,PERSON
.,O
MSc,O
;,O
Jian,PERSON
‐,PERSON
Yu,PERSON
Que,PERSON
.,O
MSc,O
;,O
Xiao,PERSON
‐,PERSON
Lin,PERSON
Huang,PERSON
.,O
MSc,O
;,O
Lin,PERSON
Liu,PERSON
.,O
MSc,O
;,O
Mao,PERSON
‐,PERSON
Sheng,PERSON
Ran,PERSON
.,O
PhD,O
;,O
Yi,O
‐,O
Miao,LOCATION
Gong,LOCATION
.,O
MA,STATE_OR_PROVINCE
;,O
Kai,PERSON
Yuan,PERSON
.,O
PhD,O
;,O
Wei,PERSON
Yan,PERSON
.,O
PhD,O
;,O
Yan,PERSON
‐,PERSON
Kun,PERSON
Sun,PERSON
.,O
PhD,O
;,O
Jie,PERSON
Shi,PERSON
.,O
MD,STATE_OR_PROVINCE
.,O
PhD,O
;,O
Yan,PERSON
‐,PERSON
Ping,PERSON
Bao,PERSON
.,O
PhD,O
;,O
Lin,PERSON
Lu,PERSON
.,O
MD,STATE_OR_PROVINCE
.,O
PhD,O
Key,O
Points,O
IMPORTANCE,O
People,O
ex,O
‐,O
posed,O
to,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
and,O
a,O
series,O
of,O
im,O
‐,O
perative,O
containment,O
measures,O
could,O
be,O
psychologically,O
stressed,O
.,O
yet,O
the,O
burden,O
of,O
and,O
factors,O
associated,O
with,O
mental,O
health,O
symp,O
‐,O
toms,O
remain,O
unclear,O
.,O
Question,O
What,O
are,O
the,O
patterns,O
of,O
and,O
fac,O
‐,O
tors,O
associated,O
with,O
mental,O
health,O
conditions,O
among,O
the,O
general,TITLE
population,O
during,O
the,O
coronavirus,O
OBJECTIVE,O
To,O
investigate,O
the,O
prevalence,O
of,O
and,O
risk,O
factors,O
associated,O
with,O
mental,O
health,O
symptoms,O
in,O
the,O
general,TITLE
population,O
in,O
China,COUNTRY
during,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
outbreak,O
in,O
China,COUNTRY
?,O
Findings,O
In,O
this,O
survey,O
study,O
with,O
DESIGN,O
.,O
SETTING,O
.,O
AND,O
PARTICIPANTS,O
This,O
large,O
‐,O
sample,O
.,O
cross,O
‐,O
sectional,O
.,O
population,O
‐,O
based,O
.,O
56,NUMBER
679,NUMBER
partici,O
‐,O
pants,O
across,O
all,O
34,NUMBER
province,O
‐,O
level,O
regions,O
in,O
China,COUNTRY
.,O
27.9,PERCENT
%,PERCENT
of,O
province,O
‐,O
level,O
regions,O
in,O
China,COUNTRY
and,O
included,O
participants,O
aged,O
18,NUMBER
years,DURATION
and,O
older,O
.,O
Data,O
analysis,O
was,O
participants,O
had,O
symptoms,O
of,O
performed,O
from,O
March,DATE
to,DATE
May,DATE
2020,DATE
.,O
depression,O
.,O
31.6,PERCENT
%,PERCENT
had,O
symptoms,O
of,O
anxiety,O
.,O
29.2,PERCENT
%,PERCENT
had,O
symptoms,O
of,O
MAIN,O
OUTCOMES,O
AND,O
MEASURES,O
The,O
prevalence,O
of,O
symptoms,O
of,O
depression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
insom,O
‐,O
nia,O
.,O
and,O
24.4,PERCENT
%,PERCENT
had,O
symptoms,O
of,O
and,O
acute,O
stress,O
among,O
the,O
general,TITLE
population,O
in,O
China,COUNTRY
during,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
was,O
acute,O
stress,O
during,O
the,O
outbreak,O
.,O
evaluated,O
using,O
the,O
Patient,O
Health,O
Ques,O
‐,O
tionnaire9,O
.,O
Generalized,O
Anxiety,O
Disorder7,O
.,O
Insomnia,O
Factors,O
inde,O
‐,O
pendently,O
associated,O
with,O
Severity,MISC
Index,MISC
.,O
and,O
Acute,O
Stress,O
Disor,O
‐,O
der,O
Scale,O
.,O
Logistic,MISC
regression,O
analyses,O
were,O
used,O
to,O
explore,O
neg,O
‐,O
ative,O
mental,O
health,O
outcomes,O
demographic,O
and,O
COVID,O
‐,O
19related,O
risk,O
factors,O
.,O
included,O
having,O
confirmed,O
or,O
suspected,O
COVID,O
‐,O
19,NUMBER
.,O
having,O
a,O
relative,O
with,O
RESULTS,O
Of,O
71,NUMBER
227,NUMBER
individuals,O
who,O
clicked,O
on,O
the,O
survey,O
link,O
.,O
56,NUMBER
932,NUMBER
submitted,O
the,O
questionnaires,O
.,O
confirmed,O
or,O
suspected,O
COVID,O
‐,O
19,NUMBER
.,O
for,O
a,O
participation,O
rate,O
of,O
79.9,PERCENT
%,PERCENT
.,O
After,O
ex,O
‐,O
cluding,O
the,O
invalid,O
questionnaires,O
.,O
56,NUMBER
679,NUMBER
participants,O
having,O
occupational,O
exposure,O
risks,O
.,O
(,O
mean,O
[,O
SD,STATE_OR_PROVINCE
],O
age,O
.,O
35.97,NUMBER
[,O
8.22,NUMBER
],O
years,DURATION
;,O
27,NUMBER
149,NUMBER
men,O
[,O
47.9,PERCENT
%,PERCENT
],O
),O
were,O
included,O
in,O
the,O
study,O
;,O
39,NUMBER
468,NUMBER
living,O
in,O
Hubei,STATE_OR_PROVINCE
province,O
.,O
and,O
respondents,O
(,O
69.6,PERCENT
%,PERCENT
),O
were,O
aged,O
18,DURATION
to,DURATION
39,DURATION
years,DURATION
.,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
the,O
rates,O
of,O
mental,O
experiencing,O
quarantine,O
and,O
delays,O
in,O
health,O
symptoms,O
among,O
the,O
survey,O
respon,O
‐,O
dents,O
were,O
27.9,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
27.5,PERCENT
%,PERCENT
‐,O
28.2,PERCENT
%,PERCENT
),O
for,O
depression,O
.,O
returning,O
to,O
work,O
.,O
31.6,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
31.2,PERCENT
%,PERCENT
‐,O
32.0,PERCENT
%,PERCENT
),O
for,O
anxiety,O
.,O
29.2,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
28.8,PERCENT
%,PERCENT
‐,O
29.6,PERCENT
%,PERCENT
),O
for,O
insomnia,O
.,O
and,O
24.4,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
24.0,PERCENT
%,PERCENT
‐,O
24.7,PERCENT
%,PERCENT
),O
for,O
acute,O
stress,O
.,O
Participants,O
with,O
confirmed,O
or,O
suspected,O
COVID,O
‐,O
19,NUMBER
and,O
their,O
family,O
members,O
or,O
friends,O
had,O
a,O
high,O
risk,O
for,O
symptoms,O
of,O
depression,O
(,O
adjusted,O
odds,O
ratios,O
[,O
ORs,O
],O
.,O
3.27,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.84,NUMBER
‐,O
5.80,NUMBER
],O
for,O
patients,O
;,O
1.53,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.26,NUMBER
‐,O
1.85,NUMBER
],O
for,O
family,O
or,O
friends,O
),O
.,O
anxiety,O
(,O
adjusted,O
ORs,O
.,O
2.48,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.43,NUMBER
‐,O
4.31,NUMBER
],O
for,O
pa,O
‐,O
tients,O
;,O
1.53,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.27,NUMBER
‐,O
1.84,NUMBER
],O
for,O
family,O
or,O
friends,O
),O
.,O
insomnia,O
(,O
adjusted,O
ORs,O
.,O
3.06,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.73,NUMBER
‐,O
5.43,NUMBER
],O
for,O
patients,O
;,O
1.62,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.35,NUMBER
‐,O
1.96,NUMBER
],O
for,O
family,O
or,O
friends,O
),O
.,O
and,O
acute,O
stress,O
(,O
adjusted,O
ORs,O
.,O
3.50,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
2.02,NUMBER
‐,O
6.07,NUMBER
],O
for,O
patients,O
;,O
1.77,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.462.15,NUMBER
],O
for,O
family,O
or,O
friends,O
),O
.,O
Moreover,O
.,O
people,O
with,O
occupa,O
‐,O
tional,O
exposure,O
risks,O
and,O
residents,O
in,O
Hubei,STATE_OR_PROVINCE
Meaning,O
The,O
mental,O
health,O
burden,O
associated,O
with,O
COVID,O
‐,O
19,NUMBER
is,O
considerable,O
among,O
the,O
general,TITLE
population,O
of,O
China,COUNTRY
.,O
suggesting,O
that,O
mental,O
health,O
inter,O
‐,O
ventions,O
are,O
in,O
urgent,O
demand,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
espe,O
‐,O
cially,O
for,O
some,O
at,O
‐,O
risk,O
province,O
had,O
increased,O
odds,O
of,O
symptoms,O
of,O
depression,O
(,O
adjusted,O
ORs,O
.,O
1.96,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.77,NUMBER
‐,O
2.17,NUMBER
],O
for,O
occupa,O
‐,O
tional,O
exposure,O
;,O
1.42,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.19,NUMBER
‐,O
1.68,NUMBER
],O
for,O
Hubei,STATE_OR_PROVINCE
residence,O
),O
.,O
anxiety,O
(,O
adjusted,O
ORs,O
.,O
1.93,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.75,NUMBER
‐,O
2.13,NUMBER
],O
for,O
occupational,O
exposure,O
;,O
1.54,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.30,NUMBER
‐,O
1.82,NUMBER
],O
for,O
Hubei,STATE_OR_PROVINCE
residence,O
),O
.,O
insomnia,O
(,O
adjusted,O
ORs,O
.,O
1.60,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.45,NUMBER
‐,O
1.77,NUMBER
],O
for,O
occupational,O
expo,O
‐,O
sure,O
;,O
1.20,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.01,NUMBER
‐,O
1.42,NUMBER
],O
for,O
Hubei,STATE_OR_PROVINCE
residence,O
),O
.,O
and,O
acute,O
stress,O
(,O
adjusted,O
ORs,O
.,O
1.98,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.79,NUMBER
‐,O
2.20,NUMBER
],O
for,O
occupational,O
exposure,O
;,O
1.49,NUMBER
+,O
Supplemental,O
content,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychi,O
‐,O
atry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.25,NUMBER
‐,O
1.79,NUMBER
],O
for,O
Hubei,STATE_OR_PROVINCE
res,O
‐,O
idence,O
),O
.,O
Both,O
centralized,O
quarantine,O
(,O
adjusted,O
ORs,O
.,O
1.33,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.10,NUMBER
‐,O
1.61,NUMBER
],O
for,O
depression,O
;,O
1.46,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.22,NUMBER
‐,O
1.75,NUMBER
],O
for,O
anxiety,O
;,O
1.63,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.36,NUMBER
‐,O
1.95,NUMBER
],O
for,O
insomnia,O
;,O
1.46,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.21,NUMBER
‐,O
1.77,NUMBER
],O
for,O
acute,O
stress,O
),O
and,O
home,O
quarantine,O
(,O
adjusted,O
ORs,O
.,O
1.30,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.25,NUMBER
‐,O
1.36,NUMBER
],O
for,O
depression,O
;,O
1.28,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.23,NUMBER
‐,O
1.34,NUMBER
],O
for,O
anxi,O
‐,O
ety,O
;,O
1.24,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.19,NUMBER
‐,O
1.30,NUMBER
],O
for,O
insomnia,O
;,O
1.29,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.24,NUMBER
‐,O
1.35,NUMBER
],O
for,O
acute,O
stress,O
),O
were,O
associated,O
with,O
the,O
4,NUMBER
negative,O
mental,O
health,O
outcomes,O
.,O
Being,O
at,O
work,O
was,O
associated,O
with,O
lower,O
risks,O
of,O
depression,O
(,O
adjusted,O
OR,O
.,O
0.85,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
0.79,NUMBER
‐,O
0.91,NUMBER
],O
),O
.,O
anx,O
‐,O
iety,O
(,O
adjusted,O
OR,O
.,O
0.92,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
0.86,NUMBER
‐,O
0.99,NUMBER
],O
),O
.,O
and,O
insomnia,O
(,O
ad,O
‐,O
justed,O
OR,O
.,O
0.87,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
0.81,NUMBER
‐,O
0.94,NUMBER
],O
),O
.,O
CONCLUSIONS,O
AND,O
RELEVANCE,O
The,O
results,O
of,O
this,O
survey,O
indicate,O
that,O
mental,O
health,O
symptoms,O
may,O
have,O
been,O
common,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
outbreak,O
among,O
the,O
gen,O
‐,O
eral,O
population,O
in,O
China,COUNTRY
.,O
especially,O
among,O
infected,O
individuals,O
.,O
people,O
with,O
suspected,O
infection,CAUSE_OF_DEATH
.,O
and,O
people,O
who,O
might,O
have,O
con,O
‐,O
tact,O
with,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
.,O
Some,O
measures,O
.,O
such,O
as,O
quaran,O
‐,O
tine,O
and,O
delays,O
in,O
returning,O
to,O
work,O
.,O
were,O
also,O
associated,O
with,O
mental,O
health,O
among,O
the,O
public,O
.,O
These,O
findings,O
identify,O
popula,O
‐,O
tions,O
at,O
risk,O
for,O
mental,O
health,O
problems,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
pan,O
‐,O
demic,O
and,O
may,O
help,O
in,O
implementing,O
mental,O
health,O
intervention,O
policies,O
in,O
other,O
countries,O
and,O
regions,O
.,O
In,O
December,DATE
2019,DATE
.,O
the,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
outbreak,O
occurred,O
and,O
aroused,O
global,O
attention,O
.1,NUMBER
It,O
has,O
infected,O
more,O
than,O
6.1,NUMBER
million,NUMBER
people,O
and,O
caused,O
376,NUMBER
000,NUMBER
deaths,O
worldwide,O
across,O
216,NUMBER
countries,O
.,O
areas,O
.,O
or,O
territories,O
according,O
to,O
June,DATE
3,DATE
.,DATE
2020,DATE
.,O
data,O
from,O
the,O
World,O
Health,O
Organization,O
.2,NUMBER
In,O
contrast,O
to,O
previous,O
epidemics,O
and,O
pan,O
‐,O
demics,O
.,O
such,O
as,O
severe,O
acute,O
respiratory,O
syndrome,O
and,O
Middle,LOCATION
East,LOCATION
respiratory,O
syndrome,O
.,O
COVID,O
‐,O
19,NUMBER
is,O
more,O
contagious,O
and,O
spreads,O
faster,O
.3,NUMBER
The,O
World,ORGANIZATION
Health,ORGANIZATION
Organization,ORGANIZATION
officially,O
announced,O
that,O
COVID,O
‐,O
19,NUMBER
was,O
a,O
pandemic,O
and,O
called,O
on,O
the,O
whole,O
world,O
to,O
work,O
to,O
‐,O
gether,O
to,O
confront,O
this,O
infection,CAUSE_OF_DEATH
.4,NUMBER
Compulsory,O
measures,O
.,O
such,O
as,O
implemented,O
in,O
China,COUNTRY
and,O
other,O
countries,O
to,O
impede,O
further,O
esca,O
‐,O
lation,O
of,O
the,O
pandemic,O
.5,NUMBER
‐,O
8,NUMBER
Facing,O
this,O
large,O
‐,O
scale,O
infectious,O
public,O
health,O
event,O
and,O
these,O
enormous,O
disruptions,O
to,O
daily,SET
life,O
.,O
people,O
are,O
under,O
unprecedented,O
pressure,O
and,O
are,O
experiencing,O
se,O
‐,O
vere,O
psychological,O
distress,O
.9,NUMBER
Few,O
studies,O
have,O
investigated,O
COVID,O
‐,O
19related,O
mental,O
health,O
symptoms,O
in,O
the,O
general,TITLE
population,O
.,O
One,NUMBER
pilot,TITLE
study10,O
in,O
China,COUNTRY
reported,O
that,O
nearly,O
one,NUMBER
‐,O
half,O
of,O
the,O
respondents,O
considered,O
the,O
mental,O
health,O
impact,O
of,O
COVID,O
‐,O
19,NUMBER
as,O
moderate,O
or,O
severe,O
.,O
and,O
one,NUMBER
‐,O
third,ORDINAL
exhibited,O
anxiety,O
symptoms,O
.,O
To,O
set,O
priorities,O
for,O
public,O
health,O
policies,O
and,O
implement,O
effective,O
health,O
care,O
interventions,O
.,O
the,O
prevalence,O
of,O
mental,O
health,O
symp,O
‐,O
toms,O
and,O
factors,O
that,O
are,O
associated,O
with,O
them,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
outbreak,O
need,O
to,O
be,O
determined,O
urgently,O
.,O
Thus,O
.,O
we,O
con,O
‐,O
ducted,O
a,O
large,O
‐,O
sample,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
and,O
potential,O
risk,O
factors,O
in,O
the,O
general,TITLE
population,O
in,O
China,COUNTRY
.,O
Study,O
Design,O
questionnaire,O
.,O
This,O
study,O
follows,O
the,O
American,NATIONALITY
Association,O
for,O
Public,ORGANIZATION
Opinion,ORGANIZATION
Research,ORGANIZATION
(,O
AAPOR,O
),O
reporting,O
guideline,O
.,O
JAMA,PERSON
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
Gener,O
‐,O
al,O
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
in,O
China,COUNTRY
.,O
The,O
survey,O
link,O
was,O
posted,O
on,O
the,O
website,O
.,O
We,O
used,O
a,O
convenience,O
sam,O
‐,O
pling,O
method,O
.,O
The,O
registered,O
members,O
clicked,O
the,O
link,O
on,O
the,O
platform,O
and,O
responded,O
to,O
the,O
survey,O
voluntarily,O
until,O
the,O
conve,O
‐,O
nience,O
sample,O
covered,O
all,O
34,NUMBER
province,O
‐,O
level,O
regions,O
in,O
China,COUNTRY
.,O
This,O
was,O
an,O
anonymous,O
survey,O
.,O
and,O
confidentiality,O
of,O
data,O
was,O
en,O
‐,O
sured,O
.,O
Study,O
Population,O
The,O
respondents,O
were,O
all,O
registered,O
mem,O
‐,O
bers,O
of,O
Joybuy,PERSON
.,O
A,O
total,O
of,O
71,NUMBER
227,NUMBER
individuals,O
clicked,O
on,O
the,O
sur,O
‐,O
vey,O
link,O
.,O
and,O
57,NUMBER
006,NUMBER
individuals,O
commenced,O
the,O
survey,O
.,O
among,O
whom,O
74,NUMBER
individuals,O
refused,O
to,O
provide,O
informed,O
consent,O
and,O
56,NUMBER
932,NUMBER
participants,O
provided,O
informed,O
consent,O
and,O
submitted,O
the,O
ques,O
‐,O
tionnaires,O
.,O
One,NUMBER
hundred,NUMBER
fifty,NUMBER
‐,O
six,NUMBER
questionnaires,O
that,O
did,O
not,O
provide,O
valid,O
age,O
information,O
were,O
excluded,O
from,O
the,O
analysis,O
.,O
Ninety,NUMBER
‐,O
seven,NUMBER
respondents,O
who,O
were,O
younger,O
than,O
18,DURATION
years,DURATION
were,O
also,O
present,DATE
conditions,O
.,O
Measurements,O
and,O
Covariates,O
The,O
survey,O
last,O
‐,O
ed,O
approximately,O
15,DURATION
minutes,DURATION
and,O
had,O
4,NUMBER
parts,O
.,O
The,O
first,ORDINAL
part,O
gath,O
‐,O
ered,O
demographic,O
information,O
of,O
the,O
participants,O
.,O
including,O
gen,O
‐,O
der,O
.,O
age,O
.,O
living,O
area,O
(,O
urban,O
vs,O
rural,O
),O
.,O
level,O
of,O
education,O
.,O
mari,O
‐,O
tal,O
status,O
.,O
monthly,SET
family,O
income,O
.,O
geographic,O
region,O
.,O
history,O
of,O
chronic,O
diseases,CAUSE_OF_DEATH
.,O
history,O
of,O
psychiatric,O
disorders,O
.,O
family,O
histo,O
‐,O
ry,O
of,O
psychiatric,O
disorders,O
.,O
and,O
occupation,O
.,O
The,O
second,ORDINAL
part,O
asked,O
epidemic,O
‐,O
related,O
questions,O
.,O
The,O
third,ORDINAL
part,O
evaluated,O
isola,O
‐,O
tion,O
conditions,O
and,O
social,O
attitudes,O
toward,O
The,O
fourth,ORDINAL
part,O
of,O
the,O
questionnaire,O
consisted,O
of,O
4,NUMBER
standardized,O
scales,O
.,O
including,O
the,O
Chinese,NATIONALITY
versions,O
of,O
Patient,O
Health,O
Questionnaire9,O
.11,O
General,TITLE
‐,O
ized,O
Anxiety,O
Disorder7,O
.12,O
Insomnia,O
Severity,O
Index,O
.13,O
and,O
Acute,O
Stress,O
Disorder,O
Scale,O
.14,O
which,O
measured,O
symptoms,O
of,O
depression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
.,O
respectively,O
.,O
The,O
total,O
scores,O
of,O
these,O
scales,O
were,O
interpreted,O
as,O
follows,O
:,O
Patient,O
Health,O
Questionnaire9,O
.,O
normal,O
(,O
0,NUMBER
‐,O
4,NUMBER
),O
.,O
mild,O
(,O
5,NUMBER
‐,O
9,NUMBER
),O
.,O
moderate,O
(,O
10,NUMBER
‐,O
14,NUMBER
),O
.,O
and,O
severe,O
(,O
15,NUMBER
‐,O
27,NUMBER
),O
depression,O
;,O
Generalized,O
Anxiety,O
Dis,O
‐,O
order7,O
.,O
normal,O
(,O
0,NUMBER
‐,O
4,NUMBER
),O
.,O
mild,O
(,O
5,NUMBER
‐,O
9,NUMBER
),O
.,O
moderate,O
(,O
10,NUMBER
‐,O
14,NUMBER
),O
.,O
and,O
severe,O
(,O
15,NUMBER
‐,O
21,NUMBER
),O
anxiety,O
;,O
Insomnia,MISC
Severity,MISC
Index,MISC
.,O
normal,O
(,O
0,NUMBER
‐,O
7,NUMBER
),O
.,O
sub,O
‐,O
threshold,O
(,O
8,NUMBER
‐,O
14,NUMBER
),O
.,O
moderate,O
(,O
15,NUMBER
‐,O
21,NUMBER
),O
.,O
and,O
severe,O
(,O
22,NUMBER
‐,O
28,NUMBER
),O
insomnia,O
;,O
and,O
Acute,O
Stress,O
Disorder,O
Scale,O
.,O
acute,O
stress,O
symptoms,O
(,O
a,O
disso,O
‐,O
ciative,O
cluster,O
score,O
9,NUMBER
and,O
cumulative,O
re,O
‐,O
experiencing,O
.,O
avoid,O
‐,O
ance,O
.,O
and,O
arousal,O
cluster,O
scores,O
28,NUMBER
),O
.,O
In,O
the,O
present,DATE
study,O
.,O
cut,O
‐,O
off,O
scores,O
of,O
5,NUMBER
for,O
the,O
Patient,O
Health,O
Questionnaire9,O
.,O
5,NUMBER
for,O
the,O
Generalized,O
Anxiety,O
Disorder7,O
scale,O
.,O
and,O
8,NUMBER
for,O
the,O
Insomnia,O
Severity,MISC
Index,MISC
were,O
adopted,O
to,O
detect,O
symptoms,O
of,O
depression,O
.,O
anxiety,O
.,O
and,O
insomnia,O
.,O
In,O
this,O
study,O
.,O
frontline,O
workers,O
are,O
con,O
‐,O
sidered,O
to,O
be,O
individuals,O
who,O
directly,O
participated,O
in,O
the,O
con,O
‐,O
trol,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
covering,O
a,O
wide,O
range,O
of,O
occupations,O
(,O
eg,O
.,O
medicine,O
.,O
research,O
.,O
public,O
health,O
.,O
media,O
.,O
security,O
work,O
.,O
police,O
.,O
community,O
work,O
.,O
emergency,O
material,O
delivery,O
services,O
.,O
charity,O
.,O
construction,O
.,O
management,O
.,O
and,O
psychological,O
interventions,O
),O
.,O
Frontline,O
workers,O
were,O
presumed,O
to,O
have,O
direct,O
contact,O
with,O
pa,O
‐,O
tients,O
with,O
COVID,O
‐,O
19,NUMBER
.,O
They,O
were,O
also,O
presumed,O
to,O
possess,O
personal,O
protective,O
equipment,O
when,O
they,O
were,O
in,O
contact,O
with,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
.,O
People,O
with,O
occupational,O
exposure,O
risks,O
are,O
individuals,O
who,O
did,O
not,O
necessarily,O
participate,O
in,O
COVID,O
‐,O
19,NUMBER
control,O
but,O
were,O
required,O
to,O
contact,O
people,O
at,O
work,O
and,O
could,O
subjectively,O
con,O
‐,O
ceive,O
of,O
threats,O
of,O
being,O
infected,O
.,O
including,O
sanitary,O
workers,O
.,O
taxi,O
drivers,O
.,O
and,O
supermarket,O
workers,O
.,O
among,O
others,O
.,O
They,O
were,O
presumed,O
to,O
be,O
poorly,O
equipped,O
with,O
self,O
‐,O
protective,O
measures,O
.,O
Statistical,O
Analysis,O
Descriptive,O
statistics,O
were,O
used,O
to,O
present,DATE
demographic,O
data,O
.,O
The,O
prevalence,O
of,O
symptoms,O
of,O
depression,O
.,O
anxi,O
‐,O
ety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
was,O
calculated,O
using,O
the,O
afore,O
‐,O
mentioned,O
cutoff,O
scores,O
and,O
reported,O
as,O
the,O
percentages,O
of,O
cases,O
in,O
different,O
populations,O
.,O
The,O
95,PERCENT
%,PERCENT
CIs,O
were,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
produced,O
by,O
the,O
exact,O
bino,O
‐,O
mial,O
methods,O
.,O
2,NUMBER
tests,O
were,O
used,O
to,O
compare,O
the,O
prevalence,O
of,O
mild,O
‐,O
tosevere,O
mental,O
health,O
symptoms,O
in,O
different,O
populations,O
.,O
To,O
explore,O
factors,O
potentially,O
associated,O
with,O
depression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
.,O
unadjusted,O
logistic,O
regression,O
and,O
multiple,O
logistic,O
regression,O
analyses,O
were,O
performed,O
.,O
and,O
odds,O
ratios,O
(,O
ORs,MISC
),O
and,O
95,PERCENT
%,PERCENT
CIs,O
are,O
presented,O
.,O
Two,NUMBER
‐,O
sided,O
Wald,PERSON
tests,O
were,O
conducted,O
to,O
determine,O
whether,O
the,O
ORs,O
in,O
the,O
regression,O
models,O
were,O
statistically,O
significant,O
.,O
All,O
of,O
the,O
variables,O
that,O
were,O
statistically,O
significant,O
in,O
the,O
unadjusted,O
regression,O
anal,O
‐,O
ysis,O
and,O
those,O
that,O
might,O
convey,O
important,O
information,O
were,O
en,O
‐,O
tered,O
into,O
the,O
the,O
Supplement,O
.,O
The,O
level,O
of,O
significance,O
was,O
set,O
to,O
P,O
<,O
.05,NUMBER
.,O
All,O
of,O
the,O
statistical,O
analyses,O
were,O
performed,O
using,O
SPSS,ORGANIZATION
statistical,O
software,O
version,O
22,NUMBER
(,O
IBM,ORGANIZATION
Corp,ORGANIZATION
),O
.,O
Data,O
analysis,O
was,O
performed,O
from,O
March,DATE
to,DATE
May,DATE
2020,DATE
.,O
Demographic,O
Characteris,O
‐,O
tics,O
Data,O
from,O
a,O
total,O
of,O
56,NUMBER
679,NUMBER
eligible,O
participants,O
were,O
in,O
‐,O
cluded,O
in,O
the,O
final,O
analysis,O
.,O
for,O
a,O
participation,O
rate,O
of,O
79.9,PERCENT
%,PERCENT
(,O
56,NUMBER
932,NUMBER
of,O
71,NUMBER
227,NUMBER
participants,O
),O
.,O
The,O
participants,O
included,O
in,O
the,O
analysis,O
represented,O
all,O
34,NUMBER
province,O
‐,O
level,O
regions,O
in,O
China,COUNTRY
.,O
Of,O
the,O
total,O
sample,O
.,O
27,NUMBER
149,NUMBER
participants,O
(,O
47.9,PERCENT
%,PERCENT
),O
were,O
male,O
.,O
and,O
the,O
mean,O
(,O
SD,STATE_OR_PROVINCE
),O
age,O
was,O
35.97,NUMBER
(,O
8.22,NUMBER
),O
years,DURATION
;,O
39,NUMBER
468,NUMBER
participants,O
(,O
69.6,PERCENT
%,PERCENT
),O
were,O
aged,O
18,DURATION
to,DURATION
39,DURATION
years,DURATION
.,O
Of,O
(,O
77.2,PERCENT
%,PERCENT
),O
were,O
married,O
.,O
Most,O
of,O
the,O
participants,O
(,O
52,NUMBER
839,NUMBER
participants,O
[,O
93.2,PERCENT
%,PERCENT
],O
),O
lived,O
in,O
urban,O
areas,O
.,O
and,O
2352,DATE
(,O
4.1,PERCENT
%,PERCENT
),O
were,O
from,O
Hubei,STATE_OR_PROVINCE
province,O
(,O
ie,O
.,O
the,O
province,O
most,O
severely,O
affected,O
by,O
COVID,O
‐,O
19,NUMBER
in,O
China,COUNTRY
),O
.,O
This,O
survey,O
included,O
da,O
‐,O
ta,O
from,O
100,NUMBER
individuals,O
(,O
0.2,PERCENT
%,PERCENT
),O
with,O
confirmed,O
or,O
suspected,O
cases,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
219,NUMBER
(,O
0.4,PERCENT
%,PERCENT
),O
people,O
who,O
were,O
in,O
close,O
contact,O
with,O
pa,O
‐,O
tients,O
with,O
COVID,O
‐,O
19,NUMBER
.,O
and,NUMBER
9725,DATE
(,O
17.2,PERCENT
%,PERCENT
),O
frontline,O
workers,O
.,O
Of,O
the,O
total,O
number,O
of,O
respondents,O
.,O
608,NUMBER
(,O
1.1,PERCENT
%,PERCENT
),O
had,O
at,O
least,O
1,NUMBER
family,O
member,O
or,O
friend,O
who,O
was,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
.,O
17,NUMBER
587,NUMBER
(,O
31.0,PERCENT
%,PERCENT
),O
had,O
at,O
least,O
1,NUMBER
family,O
member,O
or,O
friend,O
who,O
was,O
a,O
frontline,O
work,O
‐,O
er,O
.,O
16,NUMBER
454,NUMBER
(,O
29.0,PERCENT
%,PERCENT
),O
had,O
quarantine,O
experience,O
.,O
19,NUMBER
754,NUMBER
(,O
34.9,PERCENT
%,PERCENT
),O
were,O
not,O
yet,O
back,O
to,O
work,O
.,O
and,O
2904,DATE
(,O
5.1,PERCENT
%,PERCENT
),O
had,O
occupational,O
exposure,O
risks,O
.,O
Additional,O
demographic,O
and,O
Prevalence,O
of,O
Symptoms,O
of,O
De,O
‐,O
pression,O
.,O
Anxiety,O
.,O
Insomnia,O
.,O
and,O
Acute,O
Stress,O
The,O
prevalence,O
of,O
symptoms,O
for,O
the,O
4,NUMBER
mental,O
health,O
conditions,O
among,O
the,O
total,O
sam,O
‐,O
ple,O
was,O
27.9,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
27.5,PERCENT
%,PERCENT
‐,O
28.2,PERCENT
%,PERCENT
),O
for,O
depression,O
(,O
15,NUMBER
802,NUMBER
par,O
‐,O
ticipants,O
total,O
.,O
including,O
9688,DATE
participants,O
[,O
17.1,PERCENT
%,PERCENT
],O
with,O
mild,O
depression,O
and,O
6114,DATE
participants,O
[,O
10.8,PERCENT
%,PERCENT
],O
with,O
moderate,O
‐,O
to,O
‐,O
severe,O
depression,O
),O
.,O
31.6,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
31.2,PERCENT
%,PERCENT
‐,O
32.0,PERCENT
%,PERCENT
),O
for,O
anxiety,O
(,O
17,NUMBER
897,NUMBER
par,O
‐,O
ticipants,O
total,O
.,O
including,O
12,NUMBER
026,NUMBER
participants,O
[,O
21.2,PERCENT
%,PERCENT
],O
with,O
mild,O
anxiety,O
and,O
5871,DATE
participants,O
[,O
10.4,PERCENT
%,PERCENT
],O
with,O
moderate,O
‐,O
to,O
‐,O
severe,O
anxiety,O
),O
.,O
29.2,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
28.8,PERCENT
%,PERCENT
‐,O
29.6,PERCENT
%,PERCENT
),O
for,O
insomnia,O
(,O
16,NUMBER
564,NUMBER
par,O
‐,O
ticipants,O
total,O
.,O
including,O
13,NUMBER
308,NUMBER
participants,O
[,O
23.5,PERCENT
%,PERCENT
],O
with,O
sub,O
‐,O
threshold,O
insomnia,O
and,O
3256,DATE
participants,O
[,O
5.7,PERCENT
%,PERCENT
],O
with,O
moderate,O
‐,O
to,O
‐,O
severe,O
insomnia,O
),O
.,O
and,O
24.4,PERCENT
%,PERCENT
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
24.0,PERCENT
%,PERCENT
‐,O
24.7,PERCENT
%,PERCENT
),O
for,O
acute,O
stress,O
(,O
13,NUMBER
817,NUMBER
participants,O
),O
.,O
The,O
prevalence,O
of,O
symptoms,O
of,O
the,O
4,NUMBER
mental,O
health,O
was,O
high,O
among,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
(,O
depression,O
.,O
75.0,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
71.0,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
68.0,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
71.0,PERCENT
%,PERCENT
),O
.,O
frontline,O
workers,O
(,O
depression,O
.,O
30.4,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
34.0,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
32.4,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
27.3,PERCENT
%,PERCENT
),O
.,O
family,O
members,O
or,O
friends,O
of,O
pa,O
‐,O
tients,O
with,O
COVID,O
‐,O
19,NUMBER
(,O
depression,O
.,O
46.7,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
49.3,PERCENT
%,PERCENT
;,O
insom,O
‐,O
nia,O
.,O
48.4,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
42.4,PERCENT
%,PERCENT
),O
.,O
family,O
members,O
or,O
friends,O
of,O
frontline,O
workers,O
(,O
depression,O
.,O
29.3,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
33.1,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
31.6,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
25.3,PERCENT
%,PERCENT
),O
.,O
residents,O
of,O
Hubei,STATE_OR_PROVINCE
province,O
(,O
depres,O
‐,O
sion,O
.,O
40.8,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
44.9,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
38.3,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
33.7,PERCENT
%,PERCENT
),O
.,O
participants,O
who,O
were,O
in,O
close,O
contact,O
with,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
(,O
depression,O
.,O
53.9,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
52.1,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
56.2,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
42.9,PERCENT
%,PERCENT
),O
.,O
participants,O
who,O
had,O
been,O
to,O
Hubei,STATE_OR_PROVINCE
province,LOCATION
during,O
the,DURATION
past,DURATION
2,DURATION
months,DURATION
(,O
depression,O
.,O
37.5,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
41.5,PERCENT
%,PERCENT
;,O
in,O
‐,O
somnia,O
.,O
36.5,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
30.2,PERCENT
%,PERCENT
),O
.,O
participants,O
who,O
experienced,O
both,O
centralized,O
quarantine,O
(,O
depression,O
.,O
38.0,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
42.6,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
43.3,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
35.8,PERCENT
%,PERCENT
),O
and,O
home,O
quarantine,O
(,O
de,O
‐,O
pression,O
.,O
32.7,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
36.4,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
32.9,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
28.3,PERCENT
%,PERCENT
),O
.,O
participants,O
who,O
had,O
not,O
yet,O
returned,O
to,O
work,O
(,O
depres,O
‐,O
sion,O
.,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
for,O
the,O
Total,O
Sample,O
Participants,O
.,O
No,O
.,O
(,O
%,O
),O
Age,O
.,O
y,O
Living,O
area,O
Level,O
of,O
education,O
Less,O
than,O
college,O
College,O
degree,O
or,O
higher,O
Marital,O
status,O
Monthly,SET
family,O
income,O
.,O
a,O
Geographical,MISC
region,O
.,O
China,COUNTRY
Miss,STATE_OR_PROVINCE
‐,O
ing,O
values,O
History,O
of,O
chronic,O
diseases,CAUSE_OF_DEATH
History,O
of,O
psychiatric,O
disorders,O
Family,O
history,O
of,O
psychiatric,O
disorders,O
Are,O
you,O
infect,O
‐,O
ed,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
Confirmed,O
or,O
suspected,O
cases,O
Not,O
infected,O
Are,O
you,O
a,O
frontline,O
worker,O
?,O
Have,O
any,O
of,O
your,O
family,O
members,O
or,O
friends,O
been,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychi,O
‐,O
atry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
for,O
the,O
Total,O
Sample,O
(,O
continued,O
),O
Participants,O
.,O
No,O
.,O
(,O
%,O
),O
Are,O
any,O
of,O
your,O
family,O
members,O
or,O
friends,O
frontline,O
workers,O
?,O
Have,O
you,O
come,O
in,O
close,O
contact,O
with,O
patients,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
b,O
Are,O
you,O
in,O
Hubei,STATE_OR_PROVINCE
province,LOCATION
now,DATE
?,O
Have,O
you,O
been,O
to,O
Hubei,STATE_OR_PROVINCE
province,O
in,O
the,DURATION
past,DURATION
2,DURATION
mos,DURATION
?,O
Have,O
you,O
ever,O
experi,O
‐,O
enced,O
quarantine,O
?,O
Are,O
you,O
back,O
to,O
work,O
now,DATE
?,O
Work,O
at,O
home,O
Work,O
not,O
at,O
home,O
Not,O
back,O
to,O
work,O
Are,O
you,O
likely,O
to,O
be,O
exposed,O
to,O
oth,O
‐,O
er,O
people,O
at,O
work,O
?,O
Exposed,O
to,O
patients,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
Exposed,O
to,O
patients,O
with,O
other,O
diseases,CAUSE_OF_DEATH
Exposed,O
to,O
general,TITLE
people,O
Not,O
at,O
work,O
.,O
work,O
at,O
home,O
.,O
or,O
without,O
exposure,O
to,O
people,O
at,O
work,O
Missing,O
values,O
Abbreviation,O
:,O
COVID,O
‐,O
19,NUMBER
.,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
.,O
As,O
of,O
June,DATE
10,DATE
.,DATE
2020,DATE
.,O
1,NUMBER
=,O
$,MONEY
0.14,MONEY
US,COUNTRY
.,O
Close,O
contact,O
is,O
defined,O
as,O
people,O
who,O
have,O
direct,O
contact,O
with,O
confirmed,O
or,O
suspected,O
cases,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
including,O
family,O
members,O
who,O
live,O
with,O
patients,O
.,O
colleagues,O
who,O
work,O
with,O
patients,O
.,O
classmates,O
who,O
study,O
with,O
pa,O
‐,O
tients,O
.,O
passengers,O
who,O
take,O
the,O
same,O
vehicle,O
as,O
patients,O
.,O
and,O
so,O
on,O
.,O
30.4,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
33.6,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
30.5,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
25.5,PERCENT
%,PERCENT
),O
.,O
and,O
participants,O
who,O
had,O
occupational,O
exposure,O
risks,O
(,O
de,O
‐,O
pression,O
.,O
40.2,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
45.0,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
37.1,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
37.8,PERCENT
%,PERCENT
),O
.,O
Additional,O
details,O
on,O
the,O
prevalence,O
of,O
the,O
mental,O
health,O
symptoms,O
in,O
different,O
populations,O
Factors,O
Associated,O
With,O
Symp,O
‐,O
toms,O
of,O
Depression,O
.,O
Anxiety,O
.,O
Insomnia,O
.,O
and,O
Acute,O
Stress,O
The,O
re,O
‐,O
sults,O
of,O
the,O
unadjusted,O
analysis,O
of,O
demographic,O
and,O
epidemic,O
‐,O
re,O
‐,O
lated,O
variables,O
are,O
presented,O
lower,O
income,O
levels,O
.,O
and,O
having,O
a,O
personal,O
history,O
of,O
psychiatric,O
disorders,O
were,O
still,O
found,O
to,O
be,O
associated,O
with,O
the,O
symptoms,O
of,O
depression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
.,O
Male,O
participants,O
and,O
unmarried,O
people,O
dis,O
‐,O
played,O
a,O
remarkably,O
higher,O
risk,O
for,O
depression,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
Individuals,O
with,O
confirmed,O
or,O
suspected,O
COVID,O
‐,O
19,NUMBER
had,O
at,O
least,O
twice,O
the,O
risk,O
for,O
the,O
4,NUMBER
mental,O
health,O
symptoms,O
compared,O
with,O
those,O
not,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
(,O
adjusted,O
ORs,O
.,O
3.27,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.84,NUMBER
‐,O
5.80,NUMBER
],O
for,O
depression,O
.,O
2.48,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.43,NUMBER
‐,O
4.31,NUMBER
],O
for,O
anxi,O
‐,O
ety,O
.,O
3.06,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.73,NUMBER
‐,O
5.43,NUMBER
],O
for,O
insomnia,O
.,O
and,O
3.50,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
2.02,NUMBER
‐,O
6.07,NUMBER
],O
for,O
symptoms,O
of,O
acute,O
stress,O
),O
.,O
Family,O
members,O
or,O
friends,O
of,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
were,O
also,O
susceptible,O
to,O
symp,O
‐,O
toms,O
of,O
depression,O
(,O
adjusted,O
OR,O
.,O
1.53,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.26,NUMBER
‐,O
1.85,NUMBER
),O
.,O
anxi,O
‐,O
ety,O
(,O
adjusted,O
OR,O
.,O
1.53,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.27,NUMBER
‐,O
1.84,NUMBER
),O
.,O
insomnia,O
(,O
adjusted,O
OR,STATE_OR_PROVINCE
.,O
1.62,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.35,NUMBER
‐,O
1.96,NUMBER
),O
.,O
and,O
acute,O
stress,O
symptoms,O
(,O
adjusted,O
OR,STATE_OR_PROVINCE
.,O
1.77,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.46,NUMBER
‐,O
2.15,NUMBER
),O
.,O
In,O
addition,O
.,O
associations,O
were,O
identified,O
between,O
potential,O
occupational,O
exposure,O
risks,O
to,O
pa,O
‐,O
tients,O
with,O
COVID,O
‐,O
19,NUMBER
and,O
the,O
4,NUMBER
Not,O
infected,O
Have,O
you,O
come,O
in,O
close,O
contact,O
with,O
patients,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
Are,O
any,O
of,O
your,O
family,O
members,O
or,O
friends,O
frontline,O
workers,O
?,O
Have,O
any,O
of,O
your,O
family,O
members,O
or,O
friends,O
been,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
Are,O
you,O
a,O
frontline,O
worker,O
?,O
Confirmed,O
or,O
suspected,O
cases,O
Are,O
you,O
in,O
‐,O
fected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
Living,O
area,O
Age,O
.,O
y,O
P,O
valuee,O
to,O
severe,O
Par,O
‐,O
ticipants,O
.,O
No,O
.,O
(,O
%,O
),O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,O
],O
Participants,O
.,O
No,O
.,O
(,O
%,O
),O
to,O
severe,O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,O
],O
P,O
valuee,O
Subthreshold,O
to,O
severe,O
Participants,O
.,O
No,O
.,O
(,O
%,O
),O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,O
],O
P,O
valuee,O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,O
],O
Acute,O
stressd,O
P,O
valuee,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychia,O
‐,O
try,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
Work,O
not,O
at,O
home,O
Exposed,O
to,O
pa,O
‐,O
tients,O
with,O
other,O
diseases,CAUSE_OF_DEATH
Exposed,O
to,O
general,TITLE
Not,O
at,O
work,O
.,O
work,O
at,O
home,O
.,O
or,O
without,O
exposure,O
to,O
people,O
at,O
Scores,O
of,O
8,NUMBER
to,O
14,NUMBER
on,O
the,O
Insomnia,MISC
Severity,MISC
Index,MISC
were,O
defined,O
as,O
subthreshold,O
insom,O
‐,O
nia,O
.,O
and,O
scores,O
of,O
15,NUMBER
or,O
higher,O
were,O
defined,O
as,O
moderate,O
‐,O
to,O
‐,O
se,O
‐,O
vere,O
insomnia,O
.,O
Scores,O
of,O
5,NUMBER
to,O
9,NUMBER
on,O
the,O
Generalized,O
Anxiety,O
Dis,O
‐,O
order7,O
were,O
defined,O
as,O
mild,O
anxiety,O
.,O
and,O
scores,O
of,O
10,NUMBER
or,O
higher,O
were,O
defined,O
as,O
moderate,O
‐,O
to,O
‐,O
severe,O
anxiety,O
.,O
Scores,O
of,O
5,NUMBER
to,O
9,NUMBER
on,O
the,O
Patient,O
Health,O
Questionnaire9,O
were,O
defined,O
as,O
mild,O
depres,O
‐,O
sion,O
.,O
and,O
scores,O
of,O
10,NUMBER
or,O
higher,O
were,O
defined,O
as,O
moderate,O
‐,O
to,O
‐,O
se,O
‐,O
vere,O
depression,O
.,O
P,O
valuee,O
Abbreviation,O
:,O
COVID,O
‐,O
19,NUMBER
.,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
.,O
Exposed,O
to,O
patients,O
infected,O
with,O
Are,O
you,O
likely,O
to,O
be,O
exposed,O
to,O
other,O
people,O
at,O
work,O
?,O
Work,O
at,O
home,O
Are,O
you,O
back,O
to,O
work,O
now,DATE
?,O
Have,O
you,O
ever,O
experienced,O
quarantine,O
?,O
Have,O
you,O
been,O
to,O
Hubei,STATE_OR_PROVINCE
province,O
in,O
the,DURATION
past,DURATION
2,DURATION
mos,DURATION
?,O
Are,O
you,O
in,O
Hubei,STATE_OR_PROVINCE
prov,O
‐,O
ince,O
now,DATE
?,O
to,O
severe,O
Participants,O
.,O
No,O
.,O
(,O
%,O
),O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,MISC
],MISC
Participants,MISC
.,O
No,O
.,O
(,O
%,O
),O
to,O
severe,O
P,O
valuee,O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,O
],O
P,O
valuee,O
2,NUMBER
tests,O
were,O
used,O
to,O
compare,O
the,O
prevalence,O
of,O
mild,O
‐,O
to,O
‐,O
severe,O
mental,O
health,O
symptoms,O
in,O
different,O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,O
],O
Subthreshold,O
to,O
severe,O
Acute,O
stress,O
symptoms,O
were,O
defined,O
as,O
having,O
an,O
Acute,O
Stress,O
Disorder,O
Scale,O
dissociative,O
cluster,O
score,O
of,O
9,NUMBER
or,O
higher,O
and,O
cumulative,O
re,O
‐,O
experiencing,O
.,O
avoidance,O
.,O
and,O
arousal,O
cluster,O
scores,O
of,O
28,NUMBER
or,O
higher,O
.,O
P,O
valuee,O
Participants,O
.,O
No,O
.,O
(,O
%,O
),O
Acute,O
stressd,O
Total,O
.,O
No,O
.,O
(,O
%,O
),O
[,O
95,PERCENT
%,PERCENT
CI,O
],O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychi,O
‐,O
atry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
mental,O
health,O
outcomes,O
(,O
adjusted,O
ORs,O
.,O
1.96,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.77,NUMBER
‐,O
2.17,NUMBER
],O
for,O
depression,O
.,O
1.93,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.752.13,NUMBER
],O
for,O
anxiety,O
.,O
1.60,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.45,NUMBER
‐,O
1.77,NUMBER
],O
for,O
insomnia,O
.,O
and,O
1.98,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.79,NUMBER
‐,O
2.20,NUMBER
],O
for,O
acute,O
stress,O
symptoms,O
),O
.,O
Respondents,O
with,O
centralized,O
quarantine,O
or,O
home,O
quarantine,O
experience,O
had,O
higher,O
risks,O
than,O
those,O
without,O
quarantine,O
experience,O
of,O
having,O
depression,O
(,O
adjusted,O
ORs,O
.,O
1.33,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.10,NUMBER
‐,O
1.61,NUMBER
],O
vs,O
1.30,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.25,NUMBER
‐,O
1.36,NUMBER
],O
),O
.,O
anxiety,O
(,O
adjusted,O
ORs,O
.,O
1.46,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.22,NUMBER
‐,O
1.75,NUMBER
],O
vs,O
1.28,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.23,NUMBER
‐,O
1.34,NUMBER
],O
),O
.,O
insomnia,O
(,O
adjusted,O
ORs,O
.,O
1.63,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.36,NUMBER
‐,O
1.95,NUMBER
],O
vs,O
1.24,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.19,NUMBER
‐,O
1.30,NUMBER
],O
),O
.,O
and,O
acute,O
stress,O
symptoms,O
(,O
adjusted,O
ORs,O
.,O
1.46,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.21,NUMBER
‐,O
1.77,NUMBER
],O
vs,O
1.29,NUMBER
[,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.24,NUMBER
‐,O
1.35,NUMBER
],O
),O
.,O
Hubei,STATE_OR_PROVINCE
residents,O
also,O
demonstrated,O
a,O
higher,O
risk,O
than,O
participants,O
from,O
other,O
provinces,O
.,O
with,O
adjusted,O
ORs,O
of,O
1.42,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.19,NUMBER
‐,O
1.68,NUMBER
),O
for,O
depression,O
.,O
1.54,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.30,NUMBER
‐,O
1.82,NUMBER
),O
for,O
anxi,O
‐,O
ety,O
.,O
1.20,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.01,NUMBER
‐,O
1.42,NUMBER
),O
for,O
insomnia,O
.,O
and,O
1.49,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.25,NUMBER
‐,O
1.79,NUMBER
),O
for,O
acute,O
stress,O
symptoms,O
.,O
Nonetheless,O
.,O
being,O
at,O
work,O
was,O
associated,O
with,O
a,O
lower,O
risk,O
of,O
having,O
symptoms,O
of,O
depression,O
(,O
adjusted,O
OR,O
.,O
0.85,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
0.79,NUMBER
‐,O
0.91,NUMBER
),O
.,O
anxiety,O
(,O
adjusted,O
OR,O
.,O
0.92,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
0.86,NUMBER
‐,O
0.99,NUMBER
),O
.,O
and,O
insomnia,O
(,O
adjusted,O
OR,O
.,O
0.87,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
0.81,NUMBER
‐,O
0.94,NUMBER
),O
.,O
Frontline,O
workers,O
had,O
an,O
elevated,O
risk,O
for,O
insom,O
‐,O
nia,O
(,O
adjusted,O
OR,O
.,O
1.06,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.001.12,NUMBER
),O
and,O
acute,O
stress,O
symp,O
‐,O
toms,O
(,O
adjusted,O
OR,O
.,O
1.08,NUMBER
;,O
95,PERCENT
%,PERCENT
CI,O
.,O
1.01,NUMBER
‐,O
1.14,NUMBER
),O
.,O
and,O
being,O
a,O
close,O
contact,O
of,O
a,O
patient,O
with,O
COVID,O
‐,O
19,NUMBER
remained,O
statistically,O
signif,O
‐,O
icant,O
in,O
the,O
multivariable,O
model,TITLE
of,O
insomnia,O
(,O
1.55,NUMBER
;,O
The,O
present,DATE
study,O
investigated,O
the,O
prevalence,O
of,O
and,O
factors,O
associated,O
with,O
mental,O
health,O
symptoms,O
among,O
the,O
general,TITLE
population,O
in,O
China,COUNTRY
dur,O
‐,O
ing,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
based,O
on,O
a,O
nationwide,O
.,O
large,O
‐,O
sample,O
survey,O
.,O
Approximately,O
one,NUMBER
‐,O
quarter,O
(,O
24.4,PERCENT
%,PERCENT
),O
to,O
one,NUMBER
‐,O
third,ORDINAL
(,O
31.6,PERCENT
%,PERCENT
),O
of,O
respondents,O
exhibited,O
symptoms,O
of,O
depression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
.,O
We,O
also,O
identified,O
several,O
psychologically,O
vul,O
‐,O
nerable,O
populations,O
.,O
such,O
as,O
individuals,O
with,O
confirmed,O
or,O
sus,O
‐,O
pected,O
COVID,O
‐,O
19,NUMBER
and,O
their,O
relatives,O
.,O
respondents,O
with,O
occupation,O
‐,O
al,O
exposure,O
risks,O
.,O
those,O
who,O
experienced,O
quarantine,O
.,O
those,O
who,O
lived,O
in,O
Hubei,STATE_OR_PROVINCE
province,LOCATION
.,O
and,O
those,O
who,O
had,O
not,O
yet,O
returned,O
to,O
work,O
.,O
These,O
findings,O
provide,O
a,O
comprehensive,O
profile,O
of,O
psycho,O
‐,O
logical,O
status,O
in,O
the,O
general,TITLE
population,O
in,O
China,COUNTRY
during,O
the,O
COVID,O
‐,O
19,NUMBER
outbreak,O
and,O
may,O
contribute,O
to,O
developing,O
populationspe,O
‐,O
cific,O
mental,O
health,O
management,O
and,O
intervention,O
strategies,O
.,O
The,O
prevalence,O
of,O
mental,O
health,O
symptoms,O
in,O
the,O
present,DATE
study,O
is,O
con,O
‐,O
sistent,O
with,O
the,O
results,O
of,O
an,O
epidemiological,O
study15,O
that,O
was,O
conducted,O
in,O
early,DATE
February,DATE
2020,DATE
among,O
the,O
general,TITLE
population,O
in,O
China,COUNTRY
.,O
which,O
indicated,O
that,O
nearly,O
35,PERCENT
%,PERCENT
of,O
the,O
respondents,O
mani,O
‐,O
fested,O
psychological,O
distress,O
January,DATE
2020,DATE
found,O
that,O
nearly,O
one,NUMBER
‐,O
third,ORDINAL
of,O
respondents,O
experienced,O
moderate,O
‐,O
to,O
‐,O
severe,O
mental,O
health,O
outcomes,O
.,O
The,O
prevalence,O
of,O
these,O
mental,O
health,O
symptoms,O
during,O
this,O
period,O
of,O
the,O
pandemic,O
was,O
higher,O
than,O
before,O
the,O
outbreak,O
.,O
during,O
which,O
rates,O
of,O
moderate,O
‐,O
to,O
‐,O
severe,O
depression,O
.,O
moderate,O
‐,O
to,O
‐,O
severe,O
anxiety,O
.,O
and,O
insomnia,O
in,O
China,COUNTRY
were,O
approximately,O
6.0,PERCENT
%,PERCENT
.,O
5.3,PERCENT
%,PERCENT
.,O
and,O
15.0,PERCENT
%,PERCENT
.,O
respectively,O
.16,NUMBER
‐,O
19,NUMBER
The,O
prevalence,O
of,O
psychiatric,O
morbidities,O
during,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
epidemic,O
in,O
Singapore,COUNTRY
was,O
reported,O
to,O
be,O
22.9,PERCENT
%,PERCENT
.20,O
and,O
one,NUMBER
‐,O
third,ORDINAL
of,O
people,O
exhibited,O
psychological,O
distress,O
during,O
the,O
equine,O
influenza,CAUSE_OF_DEATH
out,O
‐,O
break,O
in,O
Australia,COUNTRY
.21,NUMBER
The,O
prevalence,O
was,O
in,O
accordance,O
with,O
pre,O
‐,O
vious,O
studies,O
of,O
such,O
psychiatric,O
problems,O
during,O
other,O
disas,O
‐,O
ters,O
.22.23,NUMBER
These,O
findings,O
indicate,O
that,O
severe,O
emotional,O
distress,O
occurs,O
among,O
the,O
general,TITLE
population,O
during,O
public,O
health,O
events,O
and,O
underscore,O
the,O
importance,O
of,O
preventing,O
and,O
treating,O
mental,O
health,O
problems,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
outbreak,O
.,O
The,O
present,DATE
study,O
identified,O
several,O
population,O
groups,O
who,O
were,O
likely,O
to,O
develop,O
mental,O
health,O
symptoms,O
.,O
Compared,O
with,O
uninfected,O
people,O
.,O
those,O
with,O
confirmed,O
or,O
suspected,O
COVID,O
‐,O
19,NUMBER
were,O
2,NUMBER
to,O
3,NUMBER
times,O
more,O
like,O
‐,O
ly,O
to,O
report,O
mental,O
health,O
symptoms,O
.,O
The,O
prevalence,O
of,O
symptoms,O
of,O
the,O
4,NUMBER
mental,O
health,O
conditions,O
was,O
high,O
among,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
(,O
depression,O
.,O
75.0,PERCENT
%,PERCENT
;,O
anxiety,O
.,O
71.0,PERCENT
%,PERCENT
;,O
insomnia,O
.,O
68.0,PERCENT
%,PERCENT
;,O
acute,O
stress,O
.,O
71.0,PERCENT
%,PERCENT
),O
.,O
This,O
is,O
partially,O
consistent,O
with,O
findings,O
among,O
patients,O
with,O
severe,O
acute,O
respiratory,O
syndrome,O
.24,NUMBER
The,O
higher,O
risk,O
of,O
mental,O
health,O
symptoms,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychi,O
‐,O
atry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
P,O
value,O
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
P,O
value,O
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
Acute,O
stressd,O
P,O
value,O
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
P,O
value,O
Age,O
.,O
y,O
Living,O
area,O
Level,O
of,O
education,O
Less,O
than,O
college,O
College,O
or,O
higher,O
Marital,O
status,O
Monthly,SET
family,O
income,O
.,O
e,O
History,O
of,O
chronic,O
diseases,CAUSE_OF_DEATH
History,O
of,O
psychiatric,O
disorders,O
Family,O
history,O
of,O
psychiatric,O
disorders,O
Are,O
you,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
Con,O
‐,O
firmed,O
or,O
suspected,O
Not,O
infected,O
Are,O
you,O
a,O
frontline,O
worker,O
?,O
Have,O
any,O
of,O
your,O
family,O
members,O
or,O
friends,O
been,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
Are,O
any,O
of,O
your,O
family,O
members,O
or,O
friends,O
frontline,O
workers,O
?,O
Have,O
you,O
come,O
in,O
close,O
contact,O
with,O
patients,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
?,O
JAMA,ORGANIZATION
Network,ORGANIZATION
Open,ORGANIZATION
|,ORGANIZATION
Psychiatry,ORGANIZATION
Mental,ORGANIZATION
Health,ORGANIZATION
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Out,O
‐,O
break,O
in,O
China,COUNTRY
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
P,O
value,O
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
P,O
value,O
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
Acute,O
stressd,O
P,O
value,O
AOR,O
(,O
95,PERCENT
%,PERCENT
CI,O
),O
P,O
value,O
Are,O
you,O
in,O
Hubei,STATE_OR_PROVINCE
province,O
now,DATE
?,O
Have,O
you,O
been,O
to,O
Hubei,STATE_OR_PROVINCE
province,O
in,O
the,DURATION
past,DURATION
2,DURATION
mos,DURATION
?,O
Have,O
you,O
ever,O
experienced,O
quarantine,O
?,O
Are,O
you,O
back,O
to,O
work,O
now,DATE
?,O
Work,O
at,O
home,O
Work,O
not,O
at,O
home,O
Not,O
back,O
to,O
work,O
Are,O
you,O
likely,O
to,O
be,O
exposed,O
to,O
other,O
people,O
at,O
work,O
?,O
Exposed,O
to,O
patients,O
infected,O
with,O
COVID,O
‐,O
19,NUMBER
Exposed,O
to,O
patients,O
with,O
other,O
diseases,CAUSE_OF_DEATH
Exposed,O
to,O
general,TITLE
people,O
Not,O
at,O
work,O
.,O
work,O
at,O
home,O
.,O
or,O
without,O
exposure,O
to,O
people,O
at,O
work,O
Abbreviations,O
:,O
AOR,O
.,O
adjusted,O
odds,O
ratio,O
;,O
COVID,O
‐,O
19,NUMBER
.,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
;,O
NA,O
.,O
not,O
available,O
(,O
variables,O
that,O
were,O
not,O
analyzed,O
because,O
they,O
were,O
not,O
statistically,O
significant,O
in,O
the,O
unadjusted,O
regression,O
model,TITLE
),O
.,O
Depression,O
was,O
defined,O
as,O
Pa,STATE_OR_PROVINCE
‐,O
tient,O
Health,O
Questionnaire9,O
score,O
of,O
5,NUMBER
or,O
higher,O
.,O
Anxiety,O
was,O
defined,O
as,O
Generalized,O
Anxiety,O
Disorder7,O
score,O
of,O
5,NUMBER
or,O
higher,O
.,O
Insomnia,O
was,O
defined,O
as,O
Insomnia,MISC
Severity,MISC
Index,MISC
score,O
of,O
8,NUMBER
or,O
higher,O
.,O
Acute,O
stress,O
was,O
defined,O
as,O
having,O
an,O
Acute,O
Stress,O
Dis,O
‐,O
order,O
Scale,O
dissociative,O
cluster,O
score,O
of,O
9,NUMBER
or,O
higher,O
and,O
cumula,O
‐,O
tive,O
re,O
‐,O
experiencing,O
.,O
avoidance,O
.,O
and,O
arousal,O
cluster,O
score,O
of,O
28,NUMBER
or,O
higher,O
.,O
As,O
of,O
June,DATE
10,DATE
.,DATE
2020,DATE
.,O
1,NUMBER
=,O
$,MONEY
0.14,MONEY
US,COUNTRY
.,O
physical,O
pain,O
.,O
and,O
adverse,O
effects,O
of,O
medications,O
that,O
are,O
used,O
to,O
treat,O
infec,O
‐,O
tions,O
.25,NUMBER
Moreover,O
.,O
family,O
members,O
and,O
friends,O
of,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
were,O
susceptible,O
to,O
mental,O
health,O
disturbances,O
.,O
We,O
found,O
that,O
nearly,O
50,PERCENT
%,PERCENT
of,O
family,O
members,O
or,O
friends,O
of,O
patients,O
with,O
COVID,O
‐,O
19,NUMBER
experienced,O
mild,O
‐,O
tosevere,O
mental,O
health,O
symptoms,O
.,O
Loved,O
ones,O
experiencing,O
negative,O
outcomes,O
during,O
disasters,CAUSE_OF_DEATH
has,O
been,O
shown,O
to,O
be,O
a,O
strong,O
catalyst,O
of,O
mental,O
health,O
disorders,O
.26.27,NUMBER
In,O
addition,O
.,O
relatives,O
of,O
patients,O
with,O
COVID,O
‐,O
19,DATE
may,DATE
worry,O
about,O
be,O
‐,O
coming,O
infected,O
themselves,O
.,O
may,O
be,O
quarantined,O
.,O
and,O
may,O
feel,O
stigmatized,O
.,O
all,O
of,O
which,O
may,O
exacerbate,O
psychological,O
dis,O
‐,O
tress,O
.28.29,NUMBER
The,O
present,DATE
study,O
also,O
found,O
that,O
people,O
with,O
occupa,O
‐,O
tional,O
exposure,O
risks,O
reported,O
greater,O
symptoms,O
of,O
depression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
.,O
People,O
who,O
work,O
in,O
high,O
‐,O
risk,O
environments,O
often,O
report,O
more,O
fatigue,O
.,O
health,O
worries,O
.,O
and,O
fear,O
.30,NUMBER
COVID,O
‐,O
19,DATE
may,DATE
be,O
symptomless,O
during,O
the,O
incubation,O
period,O
.,O
and,O
its,O
clinical,O
manifestations,O
can,O
be,O
easily,O
confused,O
with,O
those,O
of,O
normal,O
influenza,CAUSE_OF_DEATH
.31.32,NUMBER
Therefore,O
.,O
people,O
may,O
understandably,O
feel,O
a,O
threat,O
of,O
becoming,O
infected,O
by,O
being,O
exposed,O
to,O
general,TITLE
patients,O
.,O
thereby,O
affecting,O
their,O
psychological,O
well,O
‐,O
being,O
.,O
How,O
‐,O
ever,O
.,O
in,O
the,O
present,DATE
study,O
.,O
frontline,O
work,O
was,O
not,O
significantly,O
associated,O
with,O
depression,O
or,O
anxiety,O
.,O
A,O
previous,O
study33,O
sug,O
‐,O
gested,O
that,O
people,O
at,O
moderate,O
infection,CAUSE_OF_DEATH
risk,O
(,O
eg,O
.,O
individuals,O
who,O
might,O
come,O
in,O
contact,O
with,O
patients,O
with,O
suspected,O
cases,O
),O
had,O
more,O
adverse,O
mental,O
health,O
outcomes,O
than,O
those,O
at,O
high,O
risk,O
(,O
eg,O
.,O
individuals,O
who,O
worked,O
in,O
infectious,O
wards,O
),O
.,O
The,O
high,O
infection,CAUSE_OF_DEATH
risk,O
group,O
may,O
be,O
more,O
aware,O
of,O
the,O
risk,O
.,O
have,O
better,O
coping,O
skills,O
.,O
have,O
less,O
uncertainty,O
.,O
and,O
have,O
more,O
access,O
to,O
personal,O
protective,O
equipment,O
and,O
social,O
support,O
.,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
Another,O
prominent,O
finding,O
was,O
the,O
substantial,O
impact,O
of,O
quarantine,O
experience,O
on,O
mental,O
health,O
.,O
which,O
is,O
consistent,O
with,O
prior,O
studies,O
.28,NUMBER
Quarantine,O
can,O
contribute,O
to,O
poor,O
mental,O
health,O
in,O
both,O
children,O
and,O
adults,O
.23.34,NUMBER
People,O
may,O
experience,O
fear,O
of,O
infection,CAUSE_OF_DEATH
.,O
frustra,O
‐,O
tion,O
.,O
and,O
boredom,O
during,O
quarantine,O
.,O
Insufficient,O
basic,O
supplies,O
and,O
disruptions,O
of,O
information,O
flow,O
can,O
increase,O
both,O
fear,O
and,O
anxiety,O
.28,NUMBER
In,O
the,O
present,DATE
study,O
.,O
both,O
centralized,O
quarantine,O
and,O
home,O
quarantine,O
enhanced,O
the,O
odds,O
of,O
adverse,O
mental,O
health,O
out,O
‐,O
comes,O
.,O
Moreover,O
.,O
centralized,O
quarantine,O
can,O
have,O
a,O
more,O
perni,O
‐,O
cious,O
outcome,O
because,O
of,O
fear,O
of,O
infection,CAUSE_OF_DEATH
.,O
being,O
in,O
an,O
enclosed,O
space,O
.,O
and,O
being,O
in,O
an,O
unfamiliar,O
and,O
crowded,O
environment,O
.,O
The,O
environment,O
plays,O
a,O
vital,O
role,O
in,O
maintaining,O
healthy,O
emotions,O
and,O
sleep,O
.35.36,NUMBER
An,O
unfamiliar,O
and,O
crowded,O
environment,O
may,O
be,O
a,O
catalyst,O
for,O
the,O
unique,O
association,O
between,O
centralized,O
quaran,O
‐,O
tine,O
and,O
poor,O
mental,O
health,O
status,O
.,O
A,O
high,O
probability,O
of,O
symp,O
‐,O
toms,O
of,O
depression,O
and,O
anxiety,O
was,O
found,O
among,O
people,O
who,O
had,O
not,O
yet,O
returned,O
to,O
work,O
.,O
Among,O
people,O
who,O
had,O
returned,O
to,O
work,O
.,O
those,O
who,O
worked,O
at,O
home,O
had,O
a,O
higher,O
risk,O
of,O
mental,O
health,O
symp,O
‐,O
toms,O
compared,O
with,O
those,O
who,O
did,O
not,O
work,O
at,O
home,O
.,O
Being,O
occupied,O
with,O
work,O
activities,O
can,O
serve,O
as,O
a,O
distraction,O
from,O
epidemic,O
‐,O
re,O
‐,O
lated,O
information,O
.,O
Interpersonal,O
interactions,O
that,O
occur,O
with,O
conventional,O
styles,O
of,O
work,O
.,O
in,O
contrast,O
to,O
working,O
at,O
home,O
.,O
can,O
ameliorate,O
depression,O
and,O
lower,O
the,O
risk,O
of,O
mental,O
disor,O
‐,O
ders,O
.37.38,NUMBER
Our,O
results,O
imply,O
that,O
accelerating,O
peoples,O
return,O
to,O
normal,O
work,O
may,O
have,O
a,O
positive,O
influence,O
on,O
mental,O
health,O
.,O
Some,O
demographic,O
factors,O
may,O
also,O
influence,O
mental,O
health,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
Unmarried,O
status,O
and,O
lower,O
income,O
were,O
iden,O
‐,O
tified,O
as,O
risk,O
factors,O
for,O
poor,O
mental,O
health,O
outcomes,O
.,O
which,O
is,O
consistent,O
with,O
previous,O
studies,O
.39,NUMBER
‐,O
41,NUMBER
However,O
.,O
opposite,O
trends,O
were,O
observed,O
for,O
gender,O
and,O
age,O
.,O
The,O
higher,O
susceptibility,O
of,O
male,O
participants,O
to,O
mental,O
health,O
symptoms,O
during,O
the,O
crowded,O
places,O
or,O
not,O
wearing,O
masks,O
),O
and,O
higher,O
infective,O
rate,O
.42.43,NUMBER
The,O
higher,O
risk,O
of,O
mental,O
health,O
symptoms,O
among,O
younger,O
people,O
was,O
also,O
identified,O
in,O
this,O
study,O
.,O
which,O
is,O
consistent,O
with,O
a,O
to,O
the,O
fact,O
that,O
young,O
adults,O
frequently,O
engage,O
in,O
social,O
media,O
and,O
may,O
be,O
more,O
exposed,O
to,O
self,O
‐,O
reported,O
history,O
of,O
mental,O
disorders,O
in,O
this,O
study,O
was,O
low,O
.,O
which,O
might,O
be,O
attributed,O
to,O
stigma,O
toward,O
mental,O
illnesses47,O
and,O
the,O
low,O
recognition,O
rate,O
of,O
mental,O
health,O
symptoms48,O
in,O
China,COUNTRY
.,O
We,O
can,O
not,O
exclude,O
the,O
possibility,O
that,O
the,O
representativeness,O
of,O
the,O
sample,O
may,O
influence,O
the,O
proportion,O
of,O
self,O
‐,O
reported,O
mental,O
disorders,O
.,O
Strengths,O
and,O
Limitations,O
The,O
strengths,O
of,O
this,O
study,O
include,O
its,O
extensive,O
geographic,O
coverage,O
across,O
China,COUNTRY
.,O
large,O
sample,O
size,O
.,O
and,O
the,O
special,O
study,O
period,O
.,O
Participants,O
with,O
different,O
demographic,O
and,O
COVID,O
‐,O
19,NUMBER
epidemic,O
re,O
‐,O
lated,O
characteristics,O
were,O
recruited,O
from,O
all,O
34,NUMBER
province,O
‐,O
level,O
regions,O
in,O
China,COUNTRY
.,O
In,O
addition,O
.,O
to,O
the,O
best,O
of,O
our,O
knowledge,O
.,O
this,O
is,O
the,O
first,ORDINAL
study,O
that,O
has,O
systematically,O
investigated,O
the,O
prevalence,O
of,O
and,O
factors,O
associated,O
with,O
mental,O
health,O
symptoms,O
(,O
ie,O
.,O
symptoms,O
of,O
depression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
),O
by,O
standardized,O
rating,O
scales,O
among,O
the,O
general,TITLE
population,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
in,O
China,COUNTRY
.,O
Our,O
findings,O
may,O
provide,O
more,O
helpful,O
information,O
for,O
policy,O
making,O
.,O
recognition,O
of,O
high,O
‐,O
risk,O
populations,O
.,O
and,O
framework,O
design,O
for,O
population,O
‐,O
specific,O
psycho,O
‐,O
logical,O
crisis,O
sampling,O
method,O
.,O
Aside,O
from,O
posting,O
our,O
question,O
‐,O
naires,O
on,O
the,O
main,O
Joybuy,O
website,O
.,O
we,O
also,O
sent,O
proportional,O
questionnaire,O
links,O
to,O
registered,O
members,O
to,O
increase,O
the,O
re,O
‐,O
sponse,O
rate,O
.,O
Although,O
this,O
study,O
had,O
extensive,O
geographic,O
cover,O
‐,O
age,O
across,O
China,COUNTRY
and,O
a,O
large,O
sample,O
size,O
.,O
it,O
was,O
conducted,O
among,O
internet,O
users,O
who,O
were,O
young,O
and,O
highly,O
educated,O
;,O
thus,O
.,O
the,O
rep,O
‐,O
resentativeness,O
of,O
the,O
sample,O
might,O
be,O
limited,O
.,O
Second,ORDINAL
.,O
the,O
sta,O
‐,O
tus,O
of,O
mental,O
health,O
symptoms,O
was,O
based,O
on,O
the,O
respondents,O
self,O
‐,O
reports,O
rather,O
than,O
clinical,O
diagnoses,O
.,O
Third,ORDINAL
.,O
this,O
was,O
a,O
cross,O
‐,O
sectional,O
study,O
.,O
Therefore,O
.,O
associations,O
between,O
mental,O
health,O
symptoms,O
and,O
risk,O
factors,O
can,O
not,O
necessarily,O
be,O
considered,O
causal,O
relationships,O
.,O
Fourth,ORDINAL
.,O
the,O
results,O
may,O
only,O
reflect,O
mental,O
health,O
status,O
during,O
the,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Out,O
‐,O
break,O
in,O
China,COUNTRY
epidemic,O
.,O
Follow,O
‐,O
up,O
studies,O
are,O
needed,O
to,O
deter,O
‐,O
mine,O
the,O
possible,O
long,O
‐,O
term,O
mental,O
health,O
outcomes,O
associated,O
with,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
The,O
prevalence,O
of,O
symptoms,O
of,O
de,O
‐,O
pression,O
.,O
anxiety,O
.,O
insomnia,O
.,O
and,O
acute,O
stress,O
was,O
high,O
in,O
this,O
sample,O
of,O
study,O
participants,O
from,O
China,COUNTRY
during,O
the,O
COVID,O
‐,O
19,NUMBER
pan,O
‐,O
demic,O
.,O
especially,O
among,O
patients,O
with,O
confirmed,O
or,O
suspected,O
COVID,O
‐,O
19,NUMBER
and,O
their,O
family,O
members,O
and,O
friends,O
.,O
people,O
with,O
occu,O
‐,O
pational,O
exposure,O
risks,O
.,O
and,O
residents,O
of,O
Hubei,STATE_OR_PROVINCE
province,LOCATION
.,O
Perva,O
‐,O
sive,O
intervention,O
measures,O
.,O
including,O
quarantine,O
and,O
delays,O
in,O
returning,O
to,O
work,O
.,O
were,O
closely,O
associated,O
with,O
negative,O
mental,O
health,O
outcomes,O
.,O
These,O
findings,O
suggest,O
that,O
the,O
COVID,O
‐,O
19,NUMBER
pandem,O
‐,O
ic,O
may,O
have,O
severe,O
mental,O
health,O
repercussions,O
.,O
Population,O
‐,O
spe,O
‐,O
cific,O
mental,O
health,O
interventions,O
are,O
urgently,O
needed,O
to,O
meet,O
de,O
‐,O
mand,O
during,O
this,O
outbreak,O
.,O
Future,DATE
studies,O
are,O
needed,O
to,O
explore,O
the,O
association,O
of,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
with,O
mental,O
health,O
in,O
other,O
countries,O
and,O
its,O
long,O
‐,O
term,O
outcomes,O
.,O
ARTICLE,O
INFORMATION,O
JAMA,MISC
Network,MISC
Open,MISC
.,O
Beijing,CITY
.,O
China,COUNTRY
(,O
Gong,PERSON
.,O
L.,PERSON
Lu,PERSON
),O
.,O
integrity,O
of,O
the,O
data,O
and,O
the,O
accuracy,O
of,O
the,O
data,O
analysis,O
.,O
Dr,O
L.,PERSON
Shi,PERSON
and,O
Ms,O
Z.,PERSON
‐,PERSON
A.,PERSON
Lu,PERSON
contributed,O
equally,O
to,O
this,O
work,O
.,O
Concept,O
and,O
design,O
:,O
L.,PERSON
Shi,PERSON
.,O
Z.,PERSON
‐,PERSON
A.,PERSON
Lu,PERSON
.,O
Que,O
.,O
Huang,PERSON
.,O
Gong,PERSON
.,O
Yan,PERSON
.,O
J.,PERSON
Shi,PERSON
.,O
Bao,PERSON
.,O
L.,PERSON
Lu,PERSON
.,O
Ac,O
‐,O
quisition,O
.,O
analysis,O
.,O
or,O
interpretation,O
of,O
data,O
:,O
L.,PERSON
Shi,PERSON
.,O
Z.,PERSON
‐,PERSON
A.,PERSON
Lu,PERSON
.,O
Liu,PERSON
.,O
Ran,O
.,O
Yuan,PERSON
.,O
Sun,PERSON
.,O
Bao,PERSON
.,O
Statistical,O
analysis,O
:,O
L.,PERSON
Shi,PERSON
.,O
Z.,O
‐,O
A.,O
Lu,PERSON
.,O
Liu,PERSON
.,O
Yuan,PERSON
.,O
Sun,PERSON
.,O
Bao,PERSON
.,O
Obtained,O
funding,O
:,O
L.,PERSON
Shi,PERSON
.,O
Administra,O
‐,O
tive,O
.,O
technical,O
.,O
or,O
material,O
support,O
:,O
L.,PERSON
Shi,PERSON
.,O
Huang,PERSON
.,O
Gong,PERSON
.,O
Bao,PERSON
.,O
L.,PERSON
Lu,PERSON
.,O
Supervision,O
:,O
Ran,O
.,O
J.,PERSON
Shi,PERSON
.,O
Bao,PERSON
.,O
L.,PERSON
Lu,PERSON
.,O
Conflict,O
of,O
Inter,O
‐,O
est,O
Disclosures,O
:,O
None,O
.,O
Funding,O
/,O
Support,O
:,O
This,O
study,O
was,O
supported,O
by,O
grants,O
81761128036,NUMBER
.,O
81821092,NUMBER
.,O
and,NUMBER
31900805,NUMBER
from,O
the,O
National,O
Natural,ORGANIZATION
Science,ORGANIZATION
Foundation,ORGANIZATION
of,ORGANIZATION
China,ORGANIZATION
.,O
grant,O
BMU2020HKYZX008,O
from,O
the,O
Special,ORGANIZATION
Research,ORGANIZATION
Fund,ORGANIZATION
of,ORGANIZATION
Peking,ORGANIZATION
National,ORGANIZATION
Key,ORGANIZATION
Research,ORGANIZATION
and,O
De,O
‐,O
velopment,O
Program,O
of,O
China,COUNTRY
.,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Men,O
‐,O
tal,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
Role,O
of,O
the,O
Funder,O
/,O
Sponsor,O
:,O
The,O
fun,O
‐,O
ders,O
had,O
no,O
role,O
in,O
the,O
design,O
and,O
conduct,O
of,O
the,O
study,O
;,O
collec,O
‐,O
tion,O
.,O
Additional,O
Contributions,O
:,O
We,O
thank,O
all,O
of,O
the,O
participants,O
for,O
their,O
willingness,O
to,O
participate,O
in,O
the,O
study,O
and,O
the,O
time,O
that,O
they,O
devoted,O
to,O
the,O
study,O
.,O
1,NUMBER
.,O
Wang,PERSON
C,PERSON
.,O
Horby,LOCATION
PW,LOCATION
.,O
Hayden,PERSON
FG,O
.,O
Gao,PERSON
GF,PERSON
.,O
A,O
novel,O
coronavirus,O
outbreak,O
of,O
global,O
health,O
concern,O
.,O
Lancet,O
.,O
2020,DATE
;,O
3,NUMBER
.,O
Meo,ORGANIZATION
SA,ORGANIZATION
.,O
Alhowikan,ORGANIZATION
AM,ORGANIZATION
.,O
Al,O
‐,O
Khlaiwi,PERSON
T,O
.,O
et,O
al,O
.,O
Novel,O
coronavirus,O
2019,DATE
‐,O
nCoV,O
:,O
prevalence,O
.,O
biological,O
and,O
clinical,O
4,NUMBER
.,O
Ma,O
‐,O
hase,O
E.,O
COVID,O
‐,O
19,NUMBER
:,O
WHO,ORGANIZATION
declares,O
pandemic,O
because,O
of,O
alarming,O
lev,O
‐,O
els,O
of,O
spread,O
.,O
severity,O
.,O
and,O
inaction,O
.,O
5,NUMBER
.,O
Ebrahim,PERSON
SH,PERSON
.,O
Ahmed,PERSON
QA,PERSON
.,O
Gozzer,O
E,O
.,O
Schlagenhauf,PERSON
P,O
.,O
Memish,O
ZA,O
.,O
COVID,O
‐,O
19,NUMBER
and,O
community,O
miti,O
‐,O
gation,O
strategies,O
7,NUMBER
.,O
Chen,O
S,O
.,O
Yang,PERSON
J,PERSON
.,O
Yang,PERSON
W,PERSON
.,O
Wang,PERSON
C,PERSON
.,O
Brnighausen,PERSON
T.,O
COVID,O
‐,O
19,NUMBER
control,O
in,O
China,COUNTRY
during,O
mass,O
population,O
movements,O
8,NUMBER
.,O
Adalja,O
AA,O
.,O
Toner,PERSON
E,PERSON
.,O
Inglesby,ORGANIZATION
TV,ORGANIZATION
.,O
Priorities,O
for,O
the,O
US,COUNTRY
health,O
community,O
responding,O
to,O
COVID,O
‐,O
19,NUMBER
.,O
JAMA,ORGANIZATION
.,O
2020,DATE
;,O
9,NUMBER
.,O
Bao,O
Y,O
.,O
Sun,O
Y,O
.,O
Meng,PERSON
S,PERSON
.,O
Shi,PERSON
J,PERSON
.,O
Lu,PERSON
L.,O
2019,DATE
‐,O
nCoV,O
epidemic,O
:,O
address,O
mental,O
health,O
care,O
to,O
empower,O
society,O
.,O
Lancet,O
.,O
10,NUMBER
.,O
Wang,PERSON
C,PERSON
.,O
Pan,PERSON
R,PERSON
.,O
Wan,O
X,O
.,O
et,O
al,O
.,O
Immediate,O
psychological,O
responses,O
and,O
associated,O
factors,O
dur,O
‐,O
ing,O
the,O
initial,O
stage,O
of,O
the,O
2019,DATE
coronavirus,O
disease,CAUSE_OF_DEATH
(,O
COVID,O
‐,O
19,NUMBER
),O
epidemic,O
among,O
the,O
general,TITLE
population,O
in,O
China,COUNTRY
.,O
Int,PERSON
J,PERSON
Environ,PERSON
Res,PERSON
12,NUMBER
.,O
He,O
XY,O
.,O
Li,PERSON
CB,PERSON
.,O
Qian,PERSON
J,PERSON
.,O
Cui,PERSON
HS,PERSON
.,O
Wu,PERSON
WY,STATE_OR_PROVINCE
.,O
Reliability,O
and,O
validity,O
of,O
a,O
generalized,O
anxiety,O
disorder,O
scale,O
in,O
general,TITLE
13,NUMBER
.,O
Bai,PERSON
CJ,PERSON
.,O
Ji,PERSON
DH,O
.,O
Chen,PERSON
LX,PERSON
.,O
Li,PERSON
L,PERSON
.,O
Wang,O
CX,O
.,O
Reliability,O
and,O
validity,O
of,O
Insomnia,O
Severity,O
Index,O
in,O
clinical,O
insomnia,O
14,NUMBER
.,O
Bryant,PERSON
RA,PERSON
.,O
Moulds,PERSON
ML,O
.,O
Guthrie,PERSON
RM,O
.,O
Acute,O
Stress,O
Disorder,O
Scale,O
:,O
a,O
self,O
‐,O
report,O
measure,O
of,O
acute,O
stress,O
disorder,O
.,O
15,NUMBER
.,O
Qiu,PERSON
J,PERSON
.,O
Shen,O
B,O
.,O
Zhao,PERSON
M,O
.,O
Wang,PERSON
Z,PERSON
.,O
Xie,PERSON
B,PERSON
.,O
Xu,PERSON
Y,PERSON
.,O
A,O
nationwide,O
survey,O
of,O
psychological,O
distress,O
among,O
Chinese,NATIONALITY
people,O
in,O
the,O
COVID,O
‐,DATE
19,DATE
epidemic,O
:,O
implications,O
and,O
policy,O
recom,O
‐,O
mendations,O
.,O
Gen,TITLE
Psychiatr,O
.,O
2020,DATE
;,O
33,NUMBER
(,O
2,NUMBER
),O
:,O
e100213,O
.,O
16,NUMBER
.,O
Gupta,PERSON
S,O
.,O
Goren,PERSON
A,O
.,O
Dong,PERSON
P,PERSON
.,O
Liu,PERSON
D.,PERSON
Prevalence,PERSON
.,O
awareness,O
.,O
and,O
burden,O
of,O
ma,O
‐,O
jor,O
depressive,O
disorder,O
in,O
urban,O
17,NUMBER
.,O
Zhou,PERSON
X,PERSON
.,O
Bi,O
B,O
.,O
Zheng,PERSON
L,PERSON
.,O
et,O
al,O
.,O
The,O
prevalence,O
and,O
risk,O
factors,O
for,O
depression,O
symptoms,O
in,O
a,O
rural,O
Chinese,NATIONALITY
sample,O
18,NUMBER
.,O
Yu,O
W,O
.,O
Singh,PERSON
SS,PERSON
.,O
Calhoun,PERSON
S,O
.,O
Zhang,PERSON
H,PERSON
.,O
Zhao,PERSON
X,O
.,O
Yang,PERSON
F.,O
Generalized,O
anxiety,O
disorder,O
in,O
urban,O
China,COUNTRY
:,O
preva,O
‐,O
lence,O
.,O
20,NUMBER
.,O
Sim,PERSON
K,PERSON
.,O
Huak,O
Chan,RELIGION
Y,O
.,O
Chong,ORGANIZATION
PN,ORGANIZATION
.,O
Chua,PERSON
HC,PERSON
.,O
Wen,O
Soon,O
S.,O
Psychosocial,O
and,O
coping,O
responses,O
within,O
the,O
community,O
health,O
care,O
setting,O
towards,O
a,O
national,O
outbreak,O
of,O
an,O
infectious,O
dis,O
‐,O
ease,O
.,O
J,O
Psychosom,O
Res,O
.,O
2010,DATE
;,O
68,NUMBER
(,O
2,NUMBER
),O
:,O
21,NUMBER
.,O
Taylor,PERSON
MR,PERSON
.,O
Agho,PERSON
KE,PERSON
.,O
Stevens,PERSON
GJ,O
.,O
Raphael,PERSON
B.,PERSON
Factors,PERSON
influencing,O
psychological,O
distress,O
during,O
a,O
disease,CAUSE_OF_DEATH
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Out,O
‐,O
break,O
in,O
China,COUNTRY
22,NUMBER
.,O
van,O
Griensven,O
F,O
.,O
Chakkraband,ORGANIZATION
ML,ORGANIZATION
.,O
Thienkrua,PERSON
W,PERSON
.,O
et,O
al,O
;,O
Thailand,ORGANIZATION
Post,ORGANIZATION
‐,ORGANIZATION
Tsunami,ORGANIZATION
Mental,ORGANIZATION
Health,ORGANIZATION
Study,ORGANIZATION
Group,ORGANIZATION
.,O
Mental,O
health,O
problems,O
among,O
adults,O
in,O
tsunami,O
‐,O
affected,O
areas,O
in,O
south,O
‐,O
ern,O
Thailand,COUNTRY
.,O
JAMA,ORGANIZATION
.,O
2006,DATE
;,O
296,NUMBER
(,O
5,NUMBER
),O
:,O
23,NUMBER
.,O
Thienkrua,O
W,O
.,O
Cardozo,PERSON
BL,O
.,O
Chakkraband,O
ML,O
.,O
et,O
al,O
;,O
Thailand,ORGANIZATION
Post,ORGANIZATION
‐,O
Tsunami,O
Mental,O
Health,O
Study,O
Group,O
.,O
Symptoms,O
of,O
posttraumatic,O
stress,O
disorder,O
and,O
depression,O
among,O
children,O
in,O
tsunami,O
‐,O
affected,O
areas,O
in,O
southern,O
24,NUMBER
.,O
Cheng,PERSON
SK,STATE_OR_PROVINCE
.,O
Wong,ORGANIZATION
CW,ORGANIZATION
.,O
Tsang,PERSON
J,PERSON
.,O
Wong,PERSON
KC,O
.,O
Psychological,O
distress,O
and,O
nega,O
‐,O
tive,O
appraisals,O
in,O
survivors,O
of,O
severe,O
27,NUMBER
.,O
Tang,O
B,O
.,O
Liu,PERSON
X,PERSON
.,O
Liu,PERSON
Y,O
.,O
Xue,PERSON
C,PERSON
.,O
Zhang,PERSON
L,PERSON
.,O
A,O
meta,O
‐,O
analysis,O
of,O
risk,O
factors,O
for,O
depression,O
in,O
adults,O
and,O
children,O
after,O
28,NUMBER
.,O
Brooks,ORGANIZATION
SK,ORGANIZATION
.,O
Webster,PERSON
RK,PERSON
.,O
Smith,ORGANIZATION
LE,ORGANIZATION
.,O
et,O
al,O
.,O
The,O
psychological,O
impact,O
of,O
quarantine,O
and,O
how,O
to,O
reduce,O
it,O
:,O
rapid,O
29,NUMBER
.,O
Person,O
B,O
.,O
Sy,PERSON
F,PERSON
.,O
Holton,PERSON
K,PERSON
.,O
Govert,PERSON
B,O
.,O
Liang,PERSON
A,O
;,O
National,O
Center,O
for,O
Inectious,O
Diseases,CAUSE_OF_DEATH
/,O
SARS,O
Community,O
Outreach,O
factors,O
as,O
‐,O
sociated,O
with,O
psychological,O
outcomes,O
in,O
healthcare,O
employees,O
dur,O
‐,O
ing,O
an,O
infectious,CAUSE_OF_DEATH
disease,CAUSE_OF_DEATH
outbreak,O
.,O
31,NUMBER
.,O
Chen,O
N,O
.,O
Zhou,PERSON
M,O
.,O
Dong,PERSON
X,PERSON
.,O
et,O
al,O
.,O
Epidemiological,O
and,O
clinical,O
characteristics,O
of,O
99,NUMBER
cases,O
of,O
2019,DATE
novel,O
32,NUMBER
.,O
Bai,O
Y,O
.,O
Yao,PERSON
L,PERSON
.,O
Wei,PERSON
T,PERSON
.,O
et,O
al,O
.,O
Presumed,O
asympto,O
‐,O
matic,O
carrier,O
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
JAMA,ORGANIZATION
.,O
2020,DATE
;,O
323,NUMBER
(,O
14,NUMBER
),O
:,O
33,NUMBER
.,O
Chan,RELIGION
SS,O
.,O
Leung,ORGANIZATION
GM,ORGANIZATION
.,O
Tiwari,PERSON
AF,O
.,O
et,O
al,O
.,O
The,O
impact,O
of,O
work,O
‐,O
related,O
risk,O
on,O
nurses,O
during,O
the,O
SARS,MISC
outbreak,O
in,O
34,NUMBER
.,O
Hawryluck,O
L,O
.,O
Gold,O
WL,O
.,O
Robinson,PERSON
S,O
.,O
Pogorski,PERSON
S,PERSON
.,O
Galea,PERSON
S,O
.,O
Styra,O
R.,O
SARS,O
control,O
and,O
psychological,O
effects,O
of,O
35,NUMBER
.,O
Rautio,PERSON
N,O
.,O
Filatova,PERSON
S,PERSON
.,O
Lehtiniemi,PERSON
H,PERSON
.,O
Miettunen,O
J.,O
Living,O
environment,O
and,O
its,O
relationship,O
to,O
depres,O
‐,O
sive,O
mood,O
:,O
36,NUMBER
.,O
Andrillon,O
T,O
.,O
Poulsen,PERSON
AT,O
.,O
Hansen,PERSON
LK,PERSON
.,O
Lger,PERSON
D,PERSON
.,O
Kouider,O
S.,O
Neural,O
markers,O
of,O
responsiveness,O
to,O
the,O
environment,O
37,NUMBER
.,O
Stafford,PERSON
M,O
.,O
De,PERSON
Silva,PERSON
M,O
.,O
Stansfeld,PERSON
S,PERSON
.,O
Marmot,PERSON
M.,PERSON
Neighbourhood,PERSON
social,O
capital,O
and,O
common,O
mental,O
disorder,O
:,O
38,NUMBER
.,O
Wang,PERSON
R,PERSON
.,O
Xue,PERSON
D,PERSON
.,O
Liu,PERSON
Y,O
.,O
Chen,PERSON
H,PERSON
.,O
Qiu,PERSON
Y,PERSON
.,O
The,O
relationship,O
between,O
urbanization,O
and,O
de,O
‐,O
pression,O
in,O
China,COUNTRY
:,O
the,O
39,NUMBER
.,O
Lee,PERSON
S,PERSON
.,O
Leung,PERSON
CM,O
.,O
Kwok,PERSON
KP,PERSON
.,O
Lam,PERSON
Ng,PERSON
K.,PERSON
A,PERSON
community,O
‐,O
based,O
study,O
of,O
the,O
relationship,O
between,O
somatic,O
and,O
40,NUMBER
.,O
Stein,PERSON
DJ,PERSON
.,O
Lim,ORGANIZATION
CCW,ORGANIZATION
.,O
Roest,ORGANIZATION
AM,ORGANIZATION
.,O
et,O
al,O
;,O
WHO,O
World,O
Mental,O
Health,O
Sur,O
‐,O
vey,O
Collaborators,O
.,O
The,O
cross,O
‐,O
national,O
epidemiology,O
of,O
social,O
anx,O
‐,O
iety,O
disorder,O
:,O
data,O
from,O
the,O
World,O
Mental,O
Health,O
Survey,O
Initia,O
‐,O
tive,O
.,O
BMC,O
Med,O
.,O
2017,DATE
;,O
15,NUMBER
41,NUMBER
.,O
Dong,PERSON
X,PERSON
.,O
Wang,O
Y,O
.,O
Chen,O
Y,O
.,O
et,O
al,O
.,O
Poor,O
sleep,O
quality,O
and,O
influencing,O
factors,O
among,O
rural,O
adults,O
in,O
De,O
‐,O
qing,O
.,O
China,COUNTRY
.,O
42,NUMBER
.,O
Zhong,PERSON
BL,PERSON
.,O
Luo,PERSON
W,PERSON
.,O
Li,PERSON
HM,PERSON
.,O
et,O
al,O
.,O
Knowledge,O
.,O
atti,O
‐,O
tudes,O
.,O
and,O
practices,O
towards,O
COVID,O
‐,O
19,NUMBER
among,O
Chinese,NATIONALITY
43,NUMBER
.,O
Li,PERSON
LQ,PERSON
.,O
Huang,PERSON
T,PERSON
.,O
Wang,PERSON
YQ,PERSON
.,O
et,O
al,O
.,O
COVID,O
‐,O
19,NUMBER
patients,O
clinical,O
characteris,O
‐,O
tics,O
.,O
discharge,O
rate,O
.,O
and,O
fatality,O
rate,O
of,O
JAMA,MISC
Network,MISC
Open,MISC
|,O
Psychiatry,O
Mental,O
Health,O
Symptoms,O
Among,O
the,O
General,TITLE
Population,O
During,O
the,O
COVID,O
‐,O
19,NUMBER
Outbreak,O
in,O
China,COUNTRY
44,NUMBER
.,O
Peng,PERSON
EY,PERSON
.,O
Lee,PERSON
MB,STATE_OR_PROVINCE
.,O
Tsai,PERSON
ST,O
.,O
et,O
al,O
.,O
Population,O
‐,O
based,O
post,O
‐,O
crisis,O
psychological,O
distress,O
:,O
an,O
example,O
from,O
the,O
SARS,O
46,NUMBER
.,O
Lu,PERSON
S,PERSON
.,O
Reavley,PERSON
N,O
.,O
Zhou,PERSON
J,PERSON
.,O
et,O
al,O
.,O
De,O
‐,O
pression,O
among,O
the,O
general,TITLE
adult,O
population,O
in,O
Jiangsu,STATE_OR_PROVINCE
Province,LOCATION
of,O
China,COUNTRY
:,O
48,NUMBER
.,O
Wang,O
Y,O
.,O
Murray,ORGANIZATION
AM,ORGANIZATION
.,O
Toussaint,ORGANIZATION
AK,ORGANIZATION
.,O
et,O
al,O
.,O
Why,O
is,O
the,O
recognition,O
rate,O
of,O
psychological,O
distress,O
under,O
‐,O
estimated,O
in,O
general,TITLE
hospitals,O
?,O
a,O
cross,O
‐,O
sectional,O
observational,O
study,O
in,O
Chi,O
‐,O
na,O
.,O
Medicine,O
(,O
Baltimore,CITY
),O
.,O
2019,DATE
;,O
98,NUMBER
(,O
27,NUMBER
),O
:,O
e16274,O
.,O
Acute,O
Stress,O
